Last reviewed · How we verify

NCT06687915

Comparison of Balance and Coordination Parameters of Visually Impaired and Healthy Individuals

Completed Last updated 14 November 2024
What this trial tests

trial in Blindness Congenital in 38 participants. Completed in 1 August 2023.

Timeline
25 December 2022
Primary endpoint
22 July 2023
1 August 2023

Quick facts

Lead sponsorBahçeşehir University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment38
Start date25 December 2022
Primary completion22 July 2023
Estimated completion1 August 2023
Sites1 location across Turkey (Türkiye)

Conditions studied

Sponsor

Bahçeşehir University

Who can join

Adults 18 to 40, any sex, with Blindness Congenital. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this \[observational study\] is to examine balance in multiple aspects by comparing balance, coordination, and gait parameters between congenitally blind individuals and healthy individuals with multiple scales. The main questions it aims to answer are: Is there a difference in balance and coordination between congenitally blind individuals and healthy individuals? comparison group: Healthy sedated individuals Participants will be asked to complete balance scales.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Bahçeşehir University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06687915.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing